Voglizome, Products
VOGLIZOME 0.2
Composition:
-
Active Ingredient:
-
Voglibose: 0.2 mg
-
Formulation:
-
Form: Tablet
-
Dosage Strength: 0.2 mg of Voglibose per tablet
-
Route of Administration: Oral
Status:
-
Prescription Status: Prescription-only medication (Rx)
-
Regulatory Approval: Approved by drug regulatory authorities (such as the FDA or equivalent) for use in the management of type 2 diabetes mellitus.
Benefits:
-
Blood Sugar Control: Voglibose is an alpha-glucosidase inhibitor that helps lower blood glucose levels by slowing the digestion and absorption of carbohydrates in the intestines. This reduces postprandial (after meal) blood sugar spikes.
-
Improved Glycemic Control: Effective in managing blood sugar levels in patients with type 2 diabetes, particularly in controlling post-meal glucose excursions.
-
Complementary Therapy: Often used in combination with other antidiabetic medications to achieve better overall glycemic control in patients who do not respond adequately to monotherapy.
-
Reduced Insulin Requirement: By controlling postprandial glucose levels, Voglibose can potentially reduce the need for additional insulin or oral hypoglycemic agents.
